Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Cutaneous diffuse large B-cell lymphoma induce a macrophage immunosuppressive phenotype through IL-10 secretion

View Full Paper
Ask AI
Bookmark
Share

Authors

RPRémi PeanneJGJean Galtier

Discussion

Loading...

Member takes

Overview

Experimental findings demonstrate immunosuppressive macrophage changes in PCDLBCL-LT, indicating cytokines may promote tumor survival.

Key Points

  • This research aims to explore the interactions between macrophages and tumor B-cells in primary cutaneous DLBCL.
  • Utilized ARSI cell line and PCDLBCL-LT patient-derived xenografts for analysis.
  • Co-cultured primary monocytes and THP-1 cell line with tumor cells.
  • Conducted flow cytometry to assess macrophage activation markers.
  • Performed RNAseq for gene signature identification and cytokine profiling.
  • ARSI cell line altered macrophage phenotype, increasing CD163 and immunosuppressive factors.
  • IL-10 levels were significantly increased in macrophages after co-culture with tumor cells.
  • Macrophages inhibited T-cell proliferation and enhanced survival of PCDLBCL-LT cells under drug exposure.

Cite This Study

Peanne et al. (2025) studied this question.

synapsesocial.com/papers/693624d74fa91c937236d115https://doi.org/10.1182/blood-2025-5031
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multistep molecular trajectory during monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells2025
  2. 2Myeloid landscape profiling identifies DLBCL-specific suppressive macrophages colocalized with blood endothelial cells2025 · 5 citations
  3. 3MCP-1-CCR2-M2 macrophages axis contributes to diffuse large B-cell lymphoma progression and inhibits antitumor immune response2025 · 6 citations
  4. 4Preclinical evaluation of macrophage reprogramming in treatment of CTCL2025
  5. 5CDK7 enables adaptive gene transcription required by stromal cells to support distinct T-cell lymphoma phenotypes and represents a novel microenvironment-directed therapeutic target2025